Jensen, Thomas
Niwa, Koichiro
Hisatome, Ichiro
Kanbay, Mehmet
Andres-Hernando, Ana
Roncal-Jimenez, Carlos A.
Sato, Yuka
Garcia, Gabriela
Ohno, Minoru
Lanaspa, Miguel A.
Johnson, Richard J.
Kuwabara, Masanari http://orcid.org/0000-0002-6601-4347
Article History
Received: 18 April 2018
Accepted: 16 July 2018
First Online: 6 August 2018
Competing Interests
: Dr. Johnson has equity with XORT Therapeutics that is developing novel xanthine oxidase inhibitors and with Colorado Research Partners LLC that is developing inhibitors of fructose metabolism. In addition, Dr. Johnson is an inventor on several patents licensed to XORT Therapeutics. (US Patent No 7,799,794, US Patent No. 8,557,831).